As of April 16, 2025, Genomma Lab Internacional SAB de CV (LABB.MX) has a market cap of $1.12 billion USD. According to our data, Genomma Lab Internacional SAB de CV is ranked No.4869 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $1.12 B |
-11.13%
|
Dec 31, 2024 | $1.26 B |
86.84%
|
Dec 29, 2023 | $0.67 B |
-12.64%
|
Dec 30, 2022 | $0.77 B |
-16.10%
|
Dec 31, 2021 | $0.92 B |
21.42%
|
Dec 31, 2020 | $0.76 B |
1.40%
|
Dec 31, 2019 | $0.75 B |
59.21%
|
Dec 31, 2018 | $0.47 B |
-43.13%
|
Dec 29, 2017 | $0.82 B |
-4.65%
|
Dec 30, 2016 | $0.86 B |
55.38%
|
Dec 31, 2015 | $0.56 B |
-50.64%
|
Dec 31, 2014 | $1.13 B |
-23.67%
|
Dec 30, 2013 | $1.48 B |
38.25%
|
Dec 31, 2012 | $1.07 B |
-1.19%
|
Dec 30, 2011 | $1.08 B |
-8.00%
|
Dec 30, 2010 | $1.18 B |
103.20%
|
Dec 31, 2009 | $0.58 B |
197.11%
|
Dec 31, 2008 | $0.19 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() Procter & Gamble
PG
|
$395.04 B |
0.016 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Novo Nordisk
NVO
|
$286.98 B |
70.023 B
|
![]() Denmark
|
![]() Novo Nordisk A/S
NOVO-B.CO
|
$285.97 B |
64.050 B
|
![]() Denmark
|
![]() Roche
ROG.SW
|
$249.63 B |
38.060 B
|
![]() Switzerland
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() L'Oréal
OR.PA
|
$207.64 B |
-0.002 M
|
![]() France
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Unilever
UL
|
$152.68 B |
-0.004 M
|
![]() UK
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
![]() USA
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() CVS Health
CVS
|
$87.00 B |
-0.003 M
|
![]() USA
|
![]() Chugai Pharmaceutical
4519.T
|
$77.18 B |
0.794 B
|
![]() Japan
|
Market Cap | = | LABB.MX Stock Price | * | LABB.MX Shares Outstanding |
= | $1.12 | * | 1.00 B | |
= | $1.12 B |